Reproductive Endocrinology — MCQs

Reproductive Endocrinology Indian Medical PG Practice Questions and MCQs

Question 271: Which level of prolactin definitely suggests hyperprolactinemia?

A. 200 ng/mL (Correct Answer)
B. 150 ng/mL
C. 50 ng/mL
D. 100 ng/mL

Explanation: **Explanation:** In the context of hyperprolactinemia, serum prolactin levels are diagnostic markers for identifying the underlying etiology. While the normal upper limit for prolactin is typically **20-25 ng/mL**, the degree of elevation is highly predictive of the cause. **Why 200 ng/mL is the correct answer:** A serum prolactin level **>200 ng/mL** is considered pathognomonic for a **Prolactinoma** (specifically a macroprolactinoma). At this concentration, the elevation is so significant that it "definitely" confirms pathological hyperprolactinemia caused by a pituitary adenoma, as physiological or drug-induced causes rarely reach this threshold. **Analysis of Incorrect Options:** * **50 ng/mL:** This level is mildly elevated. It is frequently seen in physiological states (pregnancy, breastfeeding, stress, exercise) or due to "stalk effect" (compression of the pituitary stalk). * **100 ng/mL:** While clearly abnormal, this level is non-specific. It is the classic range for **drug-induced hyperprolactinemia** (e.g., antipsychotics, metoclopramide, or SSRIs). It does not definitively confirm a prolactinoma. * **150 ng/mL:** This is a high value often associated with microadenomas, but it falls below the definitive diagnostic threshold of 200 ng/mL used to distinguish major pathological tumors from other causes. **NEET-PG High-Yield Pearls:** * **Gold Standard Investigation:** MRI of the Brain (Sella turcica) with gadolinium contrast. * **First-line Treatment:** Medical management with **Dopamine agonists** (Cabergoline is preferred over Bromocriptine due to better efficacy and fewer side effects). Surgery is reserved for drug-resistant cases. * **Hook Effect:** In extremely large macroadenomas, very high prolactin levels may paradoxically read as low/normal in lab assays. Dilution of the sample is required for an accurate reading. * **Amiodarone & Verapamil:** Important non-psychotropic drugs that can cause elevated prolactin.

Question 272: A woman presents with galactorrhea and amenorrhea for 1 year. What is the most probable diagnosis?

A. Pregnancy
B. Pituitary tumor (Correct Answer)
C. Sheehan's syndrome
D. Metastasis to pituitary from other carcinoma

Explanation: ### Explanation The combination of **galactorrhea** (inappropriate milk secretion) and **amenorrhea** (absence of menses) is the classic clinical presentation of **hyperprolactinemia**. **1. Why Pituitary Tumor is Correct:** The most common pathological cause of persistent hyperprolactinemia is a **Prolactinoma** (a benign pituitary adenoma). Prolactin directly inhibits the pulsatile release of **GnRH** from the hypothalamus. This leads to decreased secretion of FSH and LH, resulting in hypogonadotropic hypogonadism, which manifests as amenorrhea. Simultaneously, high prolactin levels stimulate the mammary glands to produce milk, causing galactorrhea. **2. Analysis of Incorrect Options:** * **Pregnancy:** While pregnancy is the most common cause of secondary amenorrhea, it is typically associated with breast tenderness and enlargement rather than active galactorrhea during the gestation period (due to high progesterone levels inhibiting milk let-down). * **Sheehan’s Syndrome:** This involves postpartum pituitary necrosis. It typically presents with a **failure to lactate** (due to prolactin deficiency) and amenorrhea, rather than galactorrhea. * **Metastasis to Pituitary:** While possible, it is extremely rare compared to primary pituitary adenomas and usually presents with diabetes insipidus or multiple cranial nerve palsies. **3. High-Yield Clinical Pearls for NEET-PG:** * **First-line Investigation:** Serum Prolactin levels. If >200 ng/mL, it strongly suggests a prolactinoma. * **Gold Standard Imaging:** MRI with gadolinium enhancement (focused on the Sella Turcica). * **Drug of Choice:** **Cabergoline** (a dopamine agonist) is preferred over Bromocriptine due to better efficacy and fewer side effects. * **Hook Effect:** In cases of giant adenomas, extremely high prolactin levels may paradoxically show a low lab value; serial dilutions are required for diagnosis.

Question 273: What is the most common cause of anovulation?

A. Polycystic ovarian disease (Correct Answer)
B. Hyperprolactinemia
C. Premature ovarian failure
D. Low ovarian reserves

Explanation: **Explanation:** **Polycystic Ovarian Syndrome (PCOS)** is the most common cause of anovulatory infertility worldwide, affecting approximately 5–15% of women of reproductive age. The underlying pathophysiology involves a state of **hyperandrogenism and insulin resistance**, which disrupts the hypothalamic-pituitary-ovarian axis. Elevated levels of LH and suppressed FSH prevent the selection of a dominant follicle, leading to follicular arrest and chronic anovulation. **Analysis of Incorrect Options:** * **B. Hyperprolactinemia:** While a significant cause of secondary amenorrhea and anovulation (due to prolactin inhibiting GnRH pulsatility), it is statistically less common than PCOS. * **C. Premature Ovarian Failure (POF):** Now termed Primary Ovarian Insufficiency (POI), this involves the depletion of follicles before age 40. It is a relatively rare cause of anovulation compared to PCOS. * **D. Low Ovarian Reserves:** This refers to a decrease in the quantity and quality of oocytes (often age-related). While it leads to poor fertility outcomes, it does not necessarily cause chronic anovulation until the transition to menopause. **High-Yield Clinical Pearls for NEET-PG:** * **Rotterdam Criteria:** Diagnosis of PCOS requires 2 out of 3: (1) Clinical/biochemical hyperandrogenism, (2) Oligo/anovulation, (3) Polycystic ovaries on ultrasound (≥12 follicles or volume >10cc). * **LH:FSH Ratio:** Classically 2:1 or 3:1 in PCOS (though no longer a diagnostic requirement). * **First-line Treatment:** Weight loss and lifestyle modification. For ovulation induction, **Letrozole** is now the drug of choice (superior to Clomiphene citrate).

Question 274: A 9-year-old girl presents for evaluation of regular vaginal bleeding. History reveals thelarche at 7 years and adrenarche at 8 years. What is the most common cause of this condition in girls?

A. Idiopathic (Correct Answer)
B. Gonadal tumors
C. McCune-Albright syndrome
D. Hypothyroidism

Explanation: This clinical scenario describes **Central Precocious Puberty (CPP)**, defined as the development of secondary sexual characteristics before age 8 in girls. The sequence of events (thelarche → adrenarche → menarche) follows the normal physiological pattern but occurs prematurely due to early activation of the Hypothalamic-Pituitary-Gonadal (HPG) axis. ### **Explanation of Options** * **A. Idiopathic (Correct):** In approximately **80–90% of girls** with CPP, no identifiable organic cause is found. This is termed "Idiopathic CPP." It is a diagnosis of exclusion and is significantly more common in females than in males (where organic causes like CNS tumors are more prevalent). * **B. Gonadal Tumors:** These (e.g., Granulosa cell tumors) cause **Peripheral Precocious Puberty**. In these cases, the HPG axis is suppressed (low FSH/LH), and the sequence of puberty is often deranged. * **C. McCune-Albright Syndrome:** This is a form of peripheral precocity characterized by the triad of polyostotic fibrous dysplasia, café-au-lait spots, and autonomous endocrine overactivity. It is a rare genetic cause, not the most common. * **D. Hypothyroidism:** Severe primary hypothyroidism can cause "Van Wyk-Grumbach Syndrome," leading to precocious puberty due to high TSH levels cross-reacting with FSH receptors. This is a rare, reversible cause. ### **NEET-PG High-Yield Pearls** * **Gold Standard Investigation:** GnRH Stimulation Test. In CPP, there is a **pubertal response** (LH rise >5–10 IU/L). * **Bone Age:** Typically advanced in all forms of true precocious puberty, leading to premature epiphyseal closure and short adult stature. * **Treatment of Choice:** Long-acting **GnRH agonists** (e.g., Leuprolide) to desensitize the pituitary and halt progression. * **Gender Rule:** Precocious puberty in girls is usually **Idiopathic**; in boys, it is usually **Organic** (CNS lesions).

Question 275: Exposure of a female fetus to androgen in early embryogenesis may arrest differentiation of:

A. Mullerian ducts
B. Ovary
C. Urogenital sinus (Correct Answer)
D. Mesonephric ducts

Explanation: **Explanation:** The differentiation of the female reproductive system is primarily a "default" pathway that occurs in the absence of Anti-Müllerian Hormone (AMH) and high levels of androgens. **Why Urogenital Sinus is the Correct Answer:** In a female fetus, the **urogenital sinus (UGS)** normally differentiates into the lower 2/3rd of the vagina, the urethra, and the vestibule. This process is highly sensitive to androgens. If a female fetus is exposed to androgens during early embryogenesis (e.g., Congenital Adrenal Hyperplasia), the UGS fails to differentiate into separate vaginal and urethral openings. Instead, it undergoes **masculinization**, leading to the formation of a single urogenital sinus, clitoromegaly, and labioscrotal fusion. Thus, normal female differentiation of the UGS is arrested. **Analysis of Incorrect Options:** * **Müllerian Ducts:** These form the fallopian tubes, uterus, and upper 1/3rd of the vagina. Their regression is caused by **AMH** (produced by Sertoli cells), not androgens. In a female fetus with excess androgen, the Müllerian structures remain intact because AMH is absent. * **Ovary:** Ovarian development is determined by the presence of two X chromosomes and the absence of the SRY gene. Androgens do not arrest the formation of the ovary itself. * **Mesonephric (Wolffian) Ducts:** Androgens actually **promote** the stabilization and growth of these ducts (forming the epididymis, vas deferens, and seminal vesicles). In a normal female, they regress due to a *lack* of testosterone. **High-Yield Clinical Pearls for NEET-PG:** * **Congenital Adrenal Hyperplasia (CAH):** The most common cause of female pseudohermaphroditism; presents with normal internal female organs (Müllerian) but ambiguous external genitalia (UGS masculinization). * **Critical Period:** The UGS and external genitalia are most sensitive to androgens between **8 to 12 weeks** of gestation. * **Rule of Thumb:** Müllerian/Wolffian duct differentiation is about **hormones (AMH/Testosterone)**, while external genitalia/UGS differentiation is about **Androgens (DHT).**

Question 276: What is a characteristic feature of the post-ovulatory endometrium observed on ultrasound?

A. Single hyperechoic thin line
B. Three line sign
C. Prominent halo
D. Prominent posterior enhancement (Correct Answer)

Explanation: ### Explanation The appearance of the endometrium on ultrasound changes predictably according to the phases of the menstrual cycle, driven by the fluctuating levels of estrogen and progesterone. **Correct Answer: D. Prominent posterior enhancement** In the **secretory (post-ovulatory) phase**, progesterone causes the endometrial glands to become tortuous and filled with glycogen-rich secretions. This increased vascularity and fluid content make the endometrium **hyperechoic (bright)**. Because this thickened, secretory tissue allows sound waves to pass through efficiently compared to the surrounding myometrium, it results in **posterior acoustic enhancement** (increased brightness behind the uterus). **Incorrect Options:** * **A. Single hyperechoic thin line:** This is characteristic of the **menstrual phase** or the early follicular phase, representing the collapsed endometrial cavity after shedding. * **B. Three line sign:** This is the classic appearance of the **late proliferative (pre-ovulatory) phase**. It consists of a central echogenic line (uterine cavity) and two outer echogenic lines (basalis layer), separated by hypoechoic functionalis layers. * **C. Prominent halo:** A hypoechoic subendometrial halo is often seen in the **proliferative phase** due to inner myometrial vascularity; it is not the defining feature of the post-ovulatory phase. **Clinical Pearls for NEET-PG:** * **Proliferative Phase:** Driven by Estrogen; "Triple-line" appearance; thickness usually 4–8 mm. * **Secretory Phase:** Driven by Progesterone; "Homogeneously hyperechoic" appearance; thickness usually 7–14 mm. * **Post-menopausal Endometrium:** Should ideally be **<5 mm**. If >5 mm or bleeding occurs, a biopsy is mandatory to rule out endometrial carcinoma. * **Dating:** The "Gold Standard" for endometrial dating is the **Noyes Criteria** (histopathology), though ultrasound is the primary non-invasive tool.

Question 277: What is the most common ovarian cause of increased androgenic state?

A. Polycystic Ovarian Disease (PCOD) (Correct Answer)
B. Premature adrenarche
C. Androgen secreting tumor
D. Choriocarcinoma

Explanation: **Explanation:** **Polycystic Ovarian Disease (PCOD/PCOS)** is the most common cause of hyperandrogenism in women of reproductive age, accounting for approximately 70-80% of cases. The underlying pathophysiology involves a deranged LH:FSH ratio (typically >2:1 or 3:1). Elevated LH levels stimulate the **ovarian theca cells** to produce excess androgens (androstenedione and testosterone). This hyperandrogenic state leads to the classic clinical triad of hirsutism, acne, and anovulation. **Analysis of Incorrect Options:** * **Premature Adrenarche:** This refers to the early rise in adrenal androgens (DHEAS) before the onset of puberty. While it causes an increased androgenic state, it is an **adrenal** cause, not an ovarian one. * **Androgen Secreting Tumors:** (e.g., Sertoli-Leydig cell tumors) These cause a rapid, severe onset of virilization with very high testosterone levels (>200 ng/dL). While they are ovarian in origin, they are **rare** compared to the high prevalence of PCOD. * **Choriocarcinoma:** This is a gestational trophoblastic neoplasm. While it produces high levels of hCG (which can cause theca lutein cysts), its primary clinical manifestation is abnormal uterine bleeding and high β-hCG, not a primary androgenic state. **High-Yield Clinical Pearls for NEET-PG:** * **Rotterdam Criteria** for PCOS diagnosis (requires 2 out of 3): 1. Hyperandrogenism (clinical or biochemical), 2. Ovulatory dysfunction, 3. Polycystic ovaries on ultrasound ("String of pearls" appearance). * **Gold Standard** for diagnosing the source of androgens: Serum Testosterone (Ovary) vs. DHEAS (Adrenal). * **First-line treatment** for hirsutism in PCOS: Combined Oral Contraceptive Pills (OCPs).

Question 278: At what gestational age are the ovaries and testes first distinguishable?

A. 4 weeks
B. 8 weeks (Correct Answer)
C. 12 weeks
D. 16 weeks

Explanation: **Explanation:** The differentiation of the gonads is a critical milestone in fetal development. Up until the 6th or 7th week of gestation, the gonads are "indifferent," meaning they are morphologically identical regardless of genetic sex (XX or XY). **1. Why 8 weeks is correct:** The differentiation begins around the 7th week. In males, the **SRY gene** on the Y chromosome triggers the development of Sertoli cells and the formation of testis cords. In females, the absence of SRY (and the presence of genes like WNT4) leads to ovarian development. By the **8th week**, these histological changes are sufficiently advanced that the **testes and ovaries are morphologically distinguishable** under microscopic examination. **2. Why other options are incorrect:** * **4 weeks:** At this stage, the primordial germ cells are still migrating from the yolk sac toward the urogenital ridge. The gonadal ridge is just beginning to form. * **12 weeks:** By this time, sexual differentiation is complete. External genitalia are clearly distinguishable via ultrasound, and the ovaries contain primary oogonia. * **16 weeks:** This is a late stage where the ovaries already contain millions of primordial follicles. **Clinical Pearls for NEET-PG:** * **SRY Gene:** The "master switch" for male differentiation located on the short arm of the Y chromosome. * **Testosterone Production:** Leydig cells begin secreting testosterone by the **8th–9th week**, peaking at the 15th week. * **Müllerian Inhibiting Substance (MIS):** Secreted by Sertoli cells, it causes regression of paramesonephric ducts in males starting around the 7th–8th week. * **Germ Cell Peak:** The number of oogonia in the fetal ovary peaks at **6–7 million by the 20th week**.

Question 279: Which cells are located outside the blood-testis barrier?

A. Sertoli cells
B. Spermatocyte
C. Spermatid
D. Leydig cells (Correct Answer)

Explanation: ### Explanation The **Blood-Testis Barrier (BTB)** is a physical barrier formed by **tight junctions (zonula occludens)** between adjacent **Sertoli cells**. Its primary function is to divide the seminiferous epithelium into a basal compartment and an adluminal compartment, protecting developing germ cells from the immune system. **Why Leydig Cells are the Correct Answer:** Leydig cells are located in the **interstitial space** (the connective tissue between seminiferous tubules). Since the BTB is formed within the walls of the seminiferous tubules themselves, any cell located in the interstitium is outside this barrier. Leydig cells are exposed to systemic circulation, allowing them to respond to Luteinizing Hormone (LH) and secrete testosterone directly into the bloodstream. **Analysis of Incorrect Options:** * **Sertoli cells:** These cells actually **form** the barrier. While their nuclei are in the basal compartment, their tight junctions create the seal that defines the BTB. * **Spermatocytes:** Primary spermatocytes must cross the BTB to enter the adluminal compartment for meiosis. Once they transition, they are protected inside the barrier. * **Spermatids:** These are mature haploid cells located in the adluminal compartment, deep within the protection of the BTB, to prevent an autoimmune response against "foreign" haploid antigens. **High-Yield Clinical Pearls for NEET-PG:** * **Basal Compartment:** Contains Spermatogonia and pre-leptotene spermatocytes. * **Adluminal Compartment:** Contains Spermatocytes, Spermatids, and Spermatozoa. * **Function:** The BTB prevents **anti-sperm antibodies** from forming. Disruption of this barrier (via trauma, infection, or vasectomy) can lead to immune-mediated infertility. * **Testosterone Paradox:** While Leydig cells are outside the barrier, the testosterone they produce must cross into the tubules (aided by Androgen Binding Protein) to support spermatogenesis.

Question 280: What is the characteristic female sex chromatin?

A. XX (Correct Answer)
B. XO
C. XY
D. XXX

Explanation: **Explanation:** The characteristic female sex chromatin (karyotype) is **46,XX**. In humans, sex is determined by the presence of sex chromosomes: females typically possess two X chromosomes, while males possess one X and one Y chromosome (46,XY). **Why XX is Correct:** The presence of two X chromosomes is the genetic blueprint for female sexual differentiation. In every somatic cell of a normal female, one of the two X chromosomes undergoes inactivation (Lyonization) to become a **Barr body**. The number of Barr bodies is always $n-1$ (where $n$ is the number of X chromosomes). Thus, a normal female (XX) has one Barr body, which is a hallmark of female sex chromatin. **Analysis of Incorrect Options:** * **XO (Turner Syndrome):** This represents a female with a missing X chromosome (45,XO). These individuals are phenotypically female but lack a Barr body (chromatin negative) and typically present with streak ovaries and primary amenorrhea. * **XY (Normal Male):** This is the characteristic male sex chromatin. The presence of the **SRY gene** on the Y chromosome triggers testis differentiation. * **XXX (Triple X Syndrome):** This is a chromosomal abnormality. While phenotypically female, these individuals possess two Barr bodies per cell, which is not the "characteristic" or normal female state. **Clinical Pearls for NEET-PG:** * **Barr Body:** Best visualized in the buccal mucosal smear or as a "drumstick" in polymorphonuclear leukocytes (neutrophils). * **Lyon Hypothesis:** X-inactivation occurs early in embryonic life (around the blastocyst stage) and is random, fixed, and incomplete (some genes on the short arm of the inactive X escape inactivation). * **Gold Standard:** While Barr body testing was used historically for sex determination, **Karyotyping** is the definitive gold standard for diagnosing sex chromosome abnormalities.

Practice by Chapter

Hypothalamic-Pituitary-Ovarian Axis

Practice Questions

Disorders of Puberty

Practice Questions

Hirsutism and Virilization

Practice Questions

Primary Ovarian Insufficiency

Practice Questions

Hyperprolactinemia

Practice Questions

Hyperandrogenism

Practice Questions

Metabolic Dysfunction in PCOS

Practice Questions

Neuroendocrine Disorders and Reproduction

Practice Questions

Hormonal Evaluation and Testing

Practice Questions

Ovulation Induction

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free